(-0.12%) 5 462.58 points
(-0.31%) 38 990 points
(0.15%) 17 745 points
(0.38%) $81.14
(-3.48%) $2.66
(-0.94%) $2 309.00
(-0.32%) $28.78
(1.60%) $1 002.20
(0.30%) $0.936
(0.74%) $10.68
(0.38%) $0.791
(-0.21%) $87.31
Live Chart Being Loaded With Signals
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics...
Stats | |
---|---|
本日の出来高 | 20 366 |
平均出来高 | 0 |
時価総額 | 419.71M |
EPS | $-0.190 ( Q1 | 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Foehr Matthew W | Buy | 33 173 | Common Stock |
2024-01-02 | Foehr Matthew W | Sell | 13 221 | Common Stock |
2024-01-02 | Foehr Matthew W | Sell | 33 173 | Restricted Stock Units |
2024-01-02 | Berkman Charles S | Buy | 17 556 | Common Stock |
2024-01-02 | Berkman Charles S | Sell | 7 195 | Common Stock |
INSIDER POWER |
---|
76.05 |
Last 81 transactions |
Buy: 3 986 118 | Sell: 400 743 |
OmniAb, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
OmniAb, Inc. 財務諸表
Annual | 2023 |
収益: | $34.16M |
総利益: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2023 |
収益: | $34.16M |
総利益: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2022 |
収益: | $59.08M |
総利益: | $42.83M (72.49 %) |
EPS: | $-0.260 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company\'s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。